Neoadjuvant Targeting of GBM with Radiolabelled Substance P – Breaking a Therapeutic Dogma in Glioma Treatment?

D. Cordier, F. Forrer, M. Sailer, H. Mäcke, J. Müller & A. Merlo
Objective: We analyzed whether neoadjuvant treatment prior to tumor resection, which is an established principle in oncology for some types of cancer, is also a valid concept for improving the therapy of malignant brain tumors. In GBM, debulking surgery is regularly being performed as initial step [for full text, please go to the a.m. URL]